DS
Dr. Jessica Schneider
Chief Scientific Officer
Corundum Systems Biology
About
Category: Technology & Innovation
Track: HealthTech & Wellness
Industry: Venture Capital
Country: United States of America
Description
Jessica Schneider is the Chief Scientific Officer of Corundum Systems Biology. Prior to joining CSB, she led investment in NewCo builds for novel therapeutic modality platforms at Takeda Ventures. Jessica also built a drug discovery portfolio and led a team of scientists dedicated to microbiome therapeutics in Takeda's Gastrointestinal Drug Discovery Unit. Before Takeda, Jessica was one of the first scientists at Vedanta Biosciences where she was instrumental in building the live biotherapeutics products (LBP) platform and VE303, an LBP for the treatment of Clostridium difficile currently in Phase 3 clinical trials. Jessica holds a PhD and BS in immunology/microbiology from Cornell University and an MPH from Columbia University in New York. She completed postdoctoral studies at the Rockefeller University prior to transitioning into industry.